[
  {
    "ts": null,
    "headline": "4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks",
    "summary": "Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.",
    "url": "https://finnhub.io/api/news?id=80d1c5d14c59927f5b85502ef9f85f07b023b30f51f76abee490c0545f13634b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761920580,
      "headline": "4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks",
      "id": 137279235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.",
      "url": "https://finnhub.io/api/news?id=80d1c5d14c59927f5b85502ef9f85f07b023b30f51f76abee490c0545f13634b"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.41%: Read This Before Placing a Bet",
    "summary": "The mean of analysts' price targets for West Pharmaceutical (WST) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.",
    "url": "https://finnhub.io/api/news?id=846c699cd8c773a43542fc6f0f893e8794a5a4460494e0c709a183491910b72a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761918902,
      "headline": "Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.41%: Read This Before Placing a Bet",
      "id": 137279653,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "The mean of analysts' price targets for West Pharmaceutical (WST) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.",
      "url": "https://finnhub.io/api/news?id=846c699cd8c773a43542fc6f0f893e8794a5a4460494e0c709a183491910b72a"
    }
  },
  {
    "ts": null,
    "headline": "CFOs On the Move: Week ending Oct. 31",
    "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
    "url": "https://finnhub.io/api/news?id=4f5339e09da3ba110ddf1bcf68318b0bd049bbb1d01653c55e42d6dcf112de3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761904431,
      "headline": "CFOs On the Move: Week ending Oct. 31",
      "id": 137279193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
      "url": "https://finnhub.io/api/news?id=4f5339e09da3ba110ddf1bcf68318b0bd049bbb1d01653c55e42d6dcf112de3c"
    }
  },
  {
    "ts": null,
    "headline": "1 High-Flying Stock on Our Watchlist and 2 Facing Challenges",
    "summary": "Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.",
    "url": "https://finnhub.io/api/news?id=a0688538f7688109dee6df0708c2dfd0827af764efc85ebebf96f45fe860a260",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761885281,
      "headline": "1 High-Flying Stock on Our Watchlist and 2 Facing Challenges",
      "id": 137275119,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.",
      "url": "https://finnhub.io/api/news?id=a0688538f7688109dee6df0708c2dfd0827af764efc85ebebf96f45fe860a260"
    }
  }
]